Mark D. P. Davis

3.7k total citations
85 papers, 2.3k citations indexed

About

Mark D. P. Davis is a scholar working on Dermatology, Epidemiology and Rheumatology. According to data from OpenAlex, Mark D. P. Davis has authored 85 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Dermatology, 20 papers in Epidemiology and 18 papers in Rheumatology. Recurrent topics in Mark D. P. Davis's work include Cutaneous lymphoproliferative disorders research (13 papers), Contact Dermatitis and Allergies (13 papers) and Autoimmune Bullous Skin Diseases (12 papers). Mark D. P. Davis is often cited by papers focused on Cutaneous lymphoproliferative disorders research (13 papers), Contact Dermatitis and Allergies (13 papers) and Autoimmune Bullous Skin Diseases (12 papers). Mark D. P. Davis collaborates with scholars based in United States, Denmark and Germany. Mark D. P. Davis's co-authors include Mark R. Pittelkow, David A. Wetter, Roger H. Weenig, Roy S. Rogers, Lindsay D. Sewell, James T. McCarthy, Marian T. McEvoy, Rokea A. el‐Azhary, Alison J. Bruce and W. Michael O’Fallon and has published in prestigious journals such as Journal of the American Academy of Dermatology, Mayo Clinic Proceedings and British Journal of Dermatology.

In The Last Decade

Mark D. P. Davis

82 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. P. Davis United States 29 711 564 495 495 378 85 2.3k
Alexandra Balbir‐Gurman Israel 30 408 0.6× 932 1.7× 1.1k 2.1× 459 0.9× 106 0.3× 118 2.6k
Stefano Bombardieri Italy 30 264 0.4× 883 1.6× 804 1.6× 522 1.1× 90 0.2× 88 3.3k
Fernanda Falcini Italy 28 187 0.3× 735 1.3× 437 0.9× 214 0.4× 190 0.5× 62 2.4k
K.H. Ly France 31 466 0.7× 1.2k 2.2× 514 1.0× 400 0.8× 138 0.4× 139 2.7k
Yolanda Braun‐Moscovici Israel 23 156 0.2× 498 0.9× 469 0.9× 255 0.5× 66 0.2× 78 1.5k
Rossella De Angelis Italy 27 521 0.7× 1.1k 2.0× 672 1.4× 314 0.6× 126 0.3× 76 2.4k
Zaixing Yang China 22 89 0.1× 822 1.5× 281 0.6× 512 1.0× 100 0.3× 71 2.6k
B Devulder France 24 272 0.4× 1.0k 1.8× 644 1.3× 1.2k 2.3× 90 0.2× 188 2.9k
M. Meurer Germany 24 617 0.9× 361 0.6× 745 1.5× 393 0.8× 29 0.1× 104 1.8k
Emmanuel Chatelus France 19 314 0.4× 410 0.7× 723 1.5× 264 0.5× 63 0.2× 55 1.5k

Countries citing papers authored by Mark D. P. Davis

Since Specialization
Citations

This map shows the geographic impact of Mark D. P. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. P. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. P. Davis more than expected).

Fields of papers citing papers by Mark D. P. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. P. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. P. Davis. The network helps show where Mark D. P. Davis may publish in the future.

Co-authorship network of co-authors of Mark D. P. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. P. Davis. A scholar is included among the top collaborators of Mark D. P. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. P. Davis. Mark D. P. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ratchford, Elizabeth V, et al.. (2024). Vascular Disease Patient Information Page: Erythromelalgia. Vascular Medicine. 29(6). 735–738. 1 indexed citations
2.
Drage, Lisa A., et al.. (2024). Pediatric Patch Testing at Mayo Clinic between 2016 and 2020. Dermatitis. 35(4). 355–360. 2 indexed citations
3.
Lehman, Julia S., et al.. (2024). Direct immunofluorescence testing for skin and mucosal ulcerations: A retrospective cohort study of 352 specimens. Journal of the American Academy of Dermatology. 91(6). 1205–1207.
4.
Peter, Jonny, Karoline Krause, Petra Staubach, Maddalena Alessandra Wu, & Mark D. P. Davis. (2021). Chronic Urticaria and Recurrent Angioedema: Clues to the Mimics. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2220–2228. 5 indexed citations
5.
Veverka, Kevin K. & Mark D. P. Davis. (2020). Dubiously Doubtful: An Exploration of the Literature Concerning Doubtful, Macular Erythema, “?+,” and “+/−” Patch Test Reactions. Dermatitis. 31(1). 36–41. 5 indexed citations
6.
Shahi, Varun, et al.. (2015). Vasospasm Is a Consistent Finding in Pernio (Chilblains) and a Possible Clue to Pathogenesis. Dermatology. 231(3). 274–279. 14 indexed citations
7.
Wentworth, Ashley B. & Mark D. P. Davis. (2014). Patch Testing With the Standard Series When Receiving Immunosuppressive Medications. Dermatitis. 25(4). 195–200. 15 indexed citations
8.
Andersen, Lis Smedegaard, Julia S. Lehman, & Mark D. P. Davis. (2014). Calciphylaxis Is a Cutaneous Process Without Involvement of Internal Organs in a Retrospective Study of Postmortem Findings in Three Patients. Acta Dermato Venereologica. 94(3). 298–302. 3 indexed citations
9.
Dabade, Tushar S., Dawn Marie R. Davis, David A. Wetter, et al.. (2011). Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: Experience with 218 patients over 30 years at Mayo Clinic. Journal of the American Academy of Dermatology. 67(1). 100–106. 49 indexed citations
10.
Farmer, Sara A., et al.. (2010). An 8-Year Retrospective Review of Patch Testing with Rubber Allergens: The Mayo Clinic Experience. Dermatitis. 21(1). 33–40. 14 indexed citations
11.
Davis, Mark D. P., et al.. (2010). Results of Goeckerman Treatment for Psoriasis in Children: A 21-Year Retrospective Review. Pediatric Dermatology. 27(5). 518–524. 22 indexed citations
12.
el‐Azhary, Rokea A., Sara A. Farmer, Lisa A. Drage, et al.. (2009). Thioguanine Nucleotides and Thiopurine Methyltransferase in Immunobullous Diseases. Archives of Dermatology. 145(6). 644–52. 10 indexed citations
13.
Davis, Mark D. P., et al.. (2006). Livedoid Vasculopathy. Archives of Dermatology. 142(11). 1413–8. 109 indexed citations
14.
Reichenberg, Jason S. & Mark D. P. Davis. (2006). Picture of the Month—Quiz Case. Archives of Pediatrics and Adolescent Medicine. 160(8). 801–801. 1 indexed citations
15.
Shampo, Marc A. & Mark D. P. Davis. (2006). Dermatologists Honored on Stamps. Archives of Dermatology. 142(11). 1489–92. 3 indexed citations
16.
Comfere, Nneka I., et al.. (2005). Patch-Test Reactions to Thioureas Are Frequently Relevant. Dermatitis. 16(3). 121–121. 1 indexed citations
17.
Keeling, James H., et al.. (2003). Periorbital edema as the presenting sign of dermatomyositis. International Journal of Dermatology. 42(6). 466–467. 14 indexed citations
18.
Rogers, Roy S., Mark R. Pittelkow, Marian T. McEvoy, et al.. (2002). Topical tacrolimus in the treatment of symptomatic oral lichen planus: A series of 13 patients. Journal of the American Academy of Dermatology. 46(1). 27–34. 116 indexed citations
19.
Hsu, Te‐Shao, et al.. (2001). Cutaneous and gastrointestinal tract hemangiomas associated with disappearing bones: Gorham syndrome. International Journal of Dermatology. 40(11). 726–728. 5 indexed citations
20.
Davis, Mark D. P., et al.. (1999). Grover's Disease: Clinicopathologic Review of 72 Cases. Mayo Clinic Proceedings. 74(3). 229–234. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026